AEvit in complex treatment of acne patients

Abstract

Objective — to assess the effectiveness and tolerability of AEvit in the complex treatment of patients with acne. Materials and methods. We observed 100 patients with acne. All patients were randomly assigned to the main (50 patients) and control (50 patients) groups. Inclusion criteria were: age from 18 to 40 years; diagnosis of acne in papulo­pustular form of light or moderate severity (2—4 scores on B.S. Allen and J.G. Smith’s scale). All the patients were examined using the following methods: examination of the skin of the face, chest, back, assessment of the intensity of the inflammatory process, calculation of the elements of the rash, assessment of the severity of acne on B.S. Allen and J.G. Smith’s scale and consideration of subjective feelings of the patient, general and biochemical blood test, general urine test. Patients with acne received standard therapy. Patients of the main group were additionally prescribed AEvit 1 capsule per day after meals during 30 days. Statistical processing of the obtained results was carried out using the methods of biometric analysis implemented in the packages of licensed programs Еxcel­2003® and Statistica 6.1 (StatSoftInc., serial number AGAR909E415822FA). Results and discussion. In 23 (46.0 %) patients of the control and 28 (56.0 %) patients of the main group, the disease duration ranged from 1 to 5 years. In 15 (30.0 %) patients of the main group and 17 (34.0 %) patients of the control group the disease lasted from 6 to 10 years, and in 12 (24.0 %) patients of the main group and 5 (10.0 %) patients of the control group the disease duration was of up to 1 year. Assessment of the severity of acne on B.S. Allen and J.G. Smith’s scale was performed on 10th, 21st and 30th days of the complex treatment. Prior to treatment, the severity of acne on B.S. Allen and J.G. Smith’s scale in the main group was (3.83 ± 0.42) scores, and in the control group — (3.79 ± 0.34) scores. After treatment, the severity of acne significantly decreased in the main group to (1.43 ± 0.65) scores and in the control group — to (2.31 ± 0.18) scores. Conclusions. According to the results of the analysis, in both groups there was a statistically significant decrease in the severity of acne symptoms, the number of rash elements, the severity of acne, but in the group of patients receiving AEvit it was more pronounced.

Authors and Affiliations

A. D. Dyudyun, N. M. Polion, N. Yu. Reznichenko, S. G. Svyryd, V. V. Gorbuntsov

Keywords

Related Articles

Disbiosis of oral cavity: problem and solution

Objective — increase the effectiveness of treatment and prevention of candidiasis of oral mucosa in patients with diabetes mellitus of type 1 through the development of patogenetic reasonable method of therapy using comp...

Clinical observation of Jessner—Kanof lymphocytal infiltration on the face. Features of diagnostics and treatment

Jessner—Kanof lymphocytic infiltration refers to T-cell pseudolymphomas — reactive dermatoses that occur in response to exogenous and endogenous influences and are characterized by histological and clinical similarities...

Mechanisms of action of activated pyrithione zinc

Activation of zinc pyrithione gives it complementary pharmacodynamic properties — antimicrobial and antifungal effects, which determine its effectiveness in psoriasis and atopic dermatitis. The use of Skin-cap in these d...

Clinical cases of child progeria

Child progeria is an extremely rare disease. Not every dermatologist is lucky enough to work with such a diagnosis during medical practice. The first case of child progeria was described in 1886 by the English doctor J....

Modern view on the specifics of topical and combined therapy of onychomycosis patients

Onychomycosis is a common disease of the nail apparatus, caused by dermatophytes, fungi- saprophytes and yeast, and makes up to 50 % of all nail diseases. Onychomycosis is difficult to treat, due to the compact structure...

Download PDF file
  • EP ID EP340978
  • DOI 10.30978/UJDVK2018-2-48
  • Views 119
  • Downloads 0

How To Cite

A. D. Dyudyun, N. M. Polion, N. Yu. Reznichenko, S. G. Svyryd, V. V. Gorbuntsov (2018). AEvit in complex treatment of acne patients. Український журнал дерматології, венерології, косметології, 0(2), 48-55. https://europub.co.uk/articles/-A-340978